Evidence map›Paper›PMID 36924944›Full record

ArticleThe Journal of biological chemistry2023

Glycolipid transfer protein knockout disrupts vesicle trafficking to the plasma membrane.

Henrik Nurmi, Anders P E Backman, Josefin Halin, Max Lönnfors, Tomas Blom, Pia Roos-Mattjus, Peter Mattjus

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Impacts of Globo H Ceramide on Tumor Microenvironment.Advances in experimental medicine and biology · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Henrik NurmiDepartment of Biochemistry, Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland.
Anders P E BackmanDepartment of Biochemistry, Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland.
Josefin HalinDepartment of Biochemistry, Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland.
Max LönnforsDepartment of Biochemistry, Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland.
Tomas BlomDepartment of Anatomy and Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Pia Roos-MattjusDepartment of Biochemistry, Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland.
Peter MattjusDepartment of Biochemistry, Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland. Electronic address: peter.mattjus@abo.fi.
Åbo Akademi University · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The glycolipid transfer protein (GLTP) has been linked to many cellular processes aside from its best-known in vitro function as a lipid transport protein. It has been proposed to act as a sensor and regulator of glycosphingolipid homeostasis in cells. Furthermore, through its previously determined interaction with the endoplasmic reticulum membrane protein VAP-A (vesicle-associated membrane protein-associated protein A), GLTP may also be involved in facilitating vesicular transport in cells. In this study, we characterized the phenotype of CRISPR/Cas9-mediated GLTP KO HeLa cells. We showed that motility, three-dimensional growth, and cellular metabolism were all altered by GLTP knockout. Expression of a GLTP mutant incapable of binding VAP disrupted cell spheroid formation, indicating that the GLTP-VAP interaction is linked to cellular adhesion, cohesion, and three-dimensional growth. Most notably, we found evidence that GLTP, through its interaction with VAP-A, affects vesicular trafficking, marking the first cellular process discovered to be directly impacted by a change in GLTP expression.

Indexed as

Biological TransportCarrier ProteinsCell MembraneCell MovementCytosolGene Expression RegulationGene Knockout TechniquesHeLa CellsHumansProtein BindingVesicular Transport ProteinsCarrier Proteinslipid transfer proteinVAPA protein, humanVesicular Transport Proteinsendoplasmic reticulum (ER)gene silencingglycerosphingolipidglycolipidGolgiintracellular traffickinglipid transportsphingolipidVAP-AVSVG

Identifiers

PMID36924944
PMCPMC10140181
OpenAlexW4324135133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.